Hans Ge

Hans Ge regularly represents domestic and international corporate clients and investment banks in all aspects of corporate and securities law, with a particular focus on securities regulation, public and private offerings, SPACs, mergers and acquisitions, corporate governance and general corporate matters. Mr. Ge has extensive experience in cross-border business transactions and representing foreign private issuers.

Capital market transactions, including representation of:

• an online financial company in connection with its $7 million IPO and listing on NASDAQ
• a wealth management company in connection with its $8 million IPO and listing on NASDAQ
• an online financial company in connection with its $12 million IPO and listing on NASDAQ
• an online training and exam preparation services company in connection with its $6 million IPO and listing on NASDAQ
• a SPAC in the financial services sector in connection with its $100 million IPO and listing on NASDAQ
• a SPAC in the health food and supplements sector in connection with its $50 million IPO and listing on NASDAQ
• an online home improvement company in connection with its $20 million IPO and listing on NASDAQ
• a car service company in connection with its self-underwritten IPO and listing on OTCQB
• a crypto mining company in connection with its follow-on offerings in an aggregate amount of $300 million
• the lead underwriter in connection with the $8.75 million IPO by a global trade technology services company
• the lead underwriter in connection with the $30 million IPO by a smart food retail company
• the lead underwriter in connection with the $20 million IPO by a peer-to-peer knowledge sharing company
• the lead underwriter in connection with the $15 million IPO by a lighting system solution company
• the lead underwriter in connection with the $25 million IPO by a wealth management company
• the lead underwriter in connection with the $5.5 million follow-on offering by a clinical-stage pharmaceutical company
• the lead underwriter in connection with the $9.2 million follow-on offering by a clinical-stage bio-pharmaceutical company
• the sole sales agent in connection with the $250 million at-the-market offering by a clinical-stage bio-pharmaceutical company
• the investors in connection with the $250 million equity line of credit by a clinical-stage bio-pharmaceutical company
• an infrastructure company in connection with its $300 million shelf registration process and listing on NASDAQ
• the lead placement agent in connection with the $4.2 million registered direct offering by an agricultural technology company
• the placement agent in connection with the $2 million RD offering of a technology-enabled payment solutions company

Prior to joining Goodwin, Mr. Ge was an associate at Sullivan & Worcester LLP and Ellenoff Grossman & Schole LLP.